Gemcitabine plus platinum-based chemotherapy in combination with bevacizumab for kidney metastatic collecting duct and medullary carcinomas: Results of a prospective phase II trial (BEVABEL-GETUG/AFU24)-Reference-Cited by-同舟云学术

Gemcitabine plus platinum-based chemotherapy in combination with bevacizumab for kidney metastatic collecting duct and medullary carcinomas: Results of a prospective phase II trial (BEVABEL-GETUG/AFU24)

Published:2023-06 Issue: Volume:186 Page:83-90
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Thibault Constance^ORCID,Fléchon Aude,Albiges Laurence,Joly Charlotte,Barthelemy Philippe,Gross-Goupil Marine,Chevreau Christine,Coquan Elodie,Rolland Frédéric^ORCID,Laguerre Brigitte,Gravis Gwenaelle,Pécuchet Nicolas,Elaidi Réza-Thierry,Timsit Marc-Olivier,Brihoum Meryem,Auclin Edouard,de Reyniès Aurélien,Allory Yves^ORCID,Oudard Stéphane

Funder

Roche

Unicancer

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference34 articles.

1. Collecting duct carcinoma of kidney;Srigley;Semin Diagn Pathol,1998

2. Collecting duct carcinoma of the kidney;Fleming;Histopathology,1986

3. Collecting duct carcinoma: an entity to be redefined;Kafé;Virchows Arch,2004

4. H M, PA H, TM U, VE R. WHO classification of tumours of the urinary system and male genital organs. n.d.

5. p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system;Carvalho;Histopathology,2012

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in non‐clear cell renal cell carcinoma management: From heterogeneous biology to treatment options;International Journal of Cancer;2023-10-12